Stocks Are Going Back on Sale As Vaccine Rallies Fade

Stocks like Aphria (TSX:APHA)(NASDAQ:APHA) are going back on sale as post-election vaccine bullishness begins to recede.

Uncertainty in the markets can cause investors to make snap decisions. The U.S. election saw the markets flipflop as the democrat landslide failed to materialize. While Joe Biden has since emerged as as the president-elect, the politics of our southerly neighbours remain starkly divided. The pandemic has also thrown mixed messages into the news cycle, with rising cases pitched against vaccine hopes.

Stock market volatility continues

But uncertainty itself is not the problem. The markets were bathed in uncertainty last year. From weak oil to the trade war to valuation anxiety, 2019 had worries aplenty. But investors carried on buying right up until the March crash. Instead, the real problem right now is indecision. This can be seen in the way that the TSX Composite Index has flattened out this week.

Investors are beginning to ease back out of value stocks. But growth stocks are also slowing down at the same time. The markets are holding their breath. Markets are weighing such disparate stocks as Aphria against names like Barrick Gold and Newmont. Both asset types have seen intense momentum this year but are now grinding to a halt.

This holding pattern is fairly rare in 2020. The year to date has been typified by wildly oscillating momentum. Huge dips have been offset by heroic rips. But the current sentiment is becoming somewhat neutral. While greed has lately predominated over fear, stocks are nevertheless caught between rapidly alternating patterns.

Indeed, the CBOE Volatility Index (VIX) is currently pointing to 22.19. This sometimes overlooked indicator shows a neutral market right now. The amount of 52-week highs compared to yearlong lows is also fairly neutral at the moment. This neutrality belies a market that could flip either way.

Keep cash on hand for buying opportunities

The situation probably won’t last long, though. The vaccine bullishness that has been buoying the markets is already beginning to turn into a disillusioned selloff. With businesses still reporting earnings, there may be some upside still to be gleaned, especially from bank stocks. A resolved political situation south of the border could also help to lift stocks.

However, vaccine hopes are still 2020’s fairy gold, turning into sacks of leaves overnight. Until the uncertainties in the market are erased – from U.S. election shenanigans to the pandemic itself – then the selloffs will keep erasing the rallies.

It will take a successful vaccination program to kickstart a sustained bull run. And even then, the uncertainties that preexisted the pandemic will have to be mitigated.

Until then, bargains can still be had. Look at Aphria, for instance, down 1.3% at the time of writing. Barrick is down by the same amount,which renders both stocks key contrarian picks this week. As the reality of the pandemic continues to sink in, investors are going to be selling a lot of quality picks.

Value opportunities are therefore likely to continue opening up. By buying shares while they’re in the red, investors can continue to keep calm and carry on building positions.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »